Engene (ENGN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec2

ENGENE's Product Selected for FDA Pilot Program

13:18

enGene bladder cancer drug trial yields positive results

12:47

Nov12

Oppenheimer Analyst Reiterates Buy Rating and Price Target for enGene Holdings

13:02

UBS Analyst Maintains Hold Rating on enGene Holdings

11:32

Sep12

Engene released FY2025 9 Months Earnings on September 11 (EST) with actual revenue USD 0 and actual EPS USD -1.5588

03:00

Engene released FY2025 Q3 earnings on September 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5673 (forecast USD -0.5002)

03:00

Schedules & Filings

Schedules

Filings

Sep11

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -28.99 M, EPS -0.5673

Jun12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.82 M, EPS -0.5059

Mar10

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -24.62 M, EPS -0.4828

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change